$9.09
0.131.45%
At Close: -
$9.09
00.00%
After Hours: 4:52 PM EDT
15 minutes delayed
Comments
Loading...
Voyager Therapeutics
VYGRNASDAQ
want to know what
the Bulls & Bears Say?
Voyager Therapeutics (NASDAQ:VYGR) Stock, Analyst Ratings, Price Targets, Forecasts
Voyager Therapeutics Inc has a consensus price target of $15.3 based on the ratings of 10 analysts. The high is $30 issued by HC Wainwright & Co. on May 16, 2024. The low is $4 issued by Chardan Capital on November 3, 2021. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Oppenheimer, and Wedbush on May 16, 2024, May 15, 2024, and May 14, 2024, respectively. With an average price target of $18.67 between HC Wainwright & Co., Oppenheimer, and Wedbush, there's an implied 105.35% upside for Voyager Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Oppenheimer
Wedbush
Guggenheim
Citigroup
1calculated from analyst ratings
Analyst Ratings for Voyager Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/16/2024 | Buy Now | 230.03% | HC Wainwright & Co. | Patrick Trucchio | → $30 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 98.02% | Oppenheimer | Jay Olson | → $18 | Maintains | Outperform | Get Alert |
| 05/14/2024 | Buy Now | -11.99% | Wedbush | Laura Chico | $10 → $8 | Maintains | Neutral | Get Alert |
| 03/26/2024 | Buy Now | 142.02% | Guggenheim | Debjit Chattopadhyay | → $22 | Initiates | → Buy | Get Alert |
| 03/19/2024 | Buy Now | 230.03% | HC Wainwright & Co. | Patrick Trucchio | → $30 | Initiates | → Buy | Get Alert |
| 03/07/2024 | Buy Now | 76.02% | Citigroup | David Hoang | → $16 | Initiates | → Buy | Get Alert |
| 01/02/2024 | Buy Now | 54.02% | Wells Fargo | Yanan Zhu | $9 → $14 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/07/2023 | Buy Now | 76.02% | Oppenheimer | Jay Olson | → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2023 | Buy Now | 54.02% | Canaccord Genuity | Sumant Kulkarni | $10 → $14 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 98.02% | Truist Securities | Joon Lee | → $18 | Initiates | → Buy | Get Alert |
| 03/10/2023 | Buy Now | 54.02% | Oppenheimer | Jay Olson | → $14 | Initiates | → Outperform | Get Alert |
| 11/03/2021 | Buy Now | -56% | Chardan Capital | Geulah Livshits | — | Maintains | Neutral | Get Alert |
| 10/07/2021 | Buy Now | -0.99% | Baird | Jack Allen | — | Upgrade | Neutral → Outperform | Get Alert |
FAQ
What is the target price for Voyager Therapeutics (VYGR) stock?
The latest price target for Voyager Therapeutics (NASDAQ:VYGR) was reported by HC Wainwright & Co. on May 16, 2024. The analyst firm set a price target for $30.00 expecting VYGR to rise to within 12 months (a possible 230.03% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Voyager Therapeutics (VYGR)?
The latest analyst rating for Voyager Therapeutics (NASDAQ:VYGR) was provided by HC Wainwright & Co., and Voyager Therapeutics reiterated their buy rating.
When was the last upgrade for Voyager Therapeutics (VYGR)?
The last upgrade for Voyager Therapeutics Inc happened on January 2, 2024 when Wells Fargo raised their price target to $14. Wells Fargo previously had an equal-weight for Voyager Therapeutics Inc.
When was the last downgrade for Voyager Therapeutics (VYGR)?
There is no last downgrade for Voyager Therapeutics.
When is the next analyst rating going to be posted or updated for Voyager Therapeutics (VYGR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Voyager Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Voyager Therapeutics was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.
Is the Analyst Rating Voyager Therapeutics (VYGR) correct?
While ratings are subjective and will change, the latest Voyager Therapeutics (VYGR) rating was a reiterated with a price target of $30.00 to $30.00. The current price Voyager Therapeutics (VYGR) is trading at is $9.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.